Evaluation of a Mycobacterium avium subsp. paratuberculosis leuD mutant as a vaccine candidate against challenge in a caprine model.

Clinical and vaccine immunology : CVI

PubMedID: 23408524

Faisal SM, Chen JW, Yan F, Chen TT, Useh NM, Yan W, Guo S, Wang SJ, Glaser AL, McDonough SP, Singh B, Davis WC, Akey BL, Chang YF. Evaluation of a Mycobacterium avium subsp. paratuberculosis leuD mutant as a vaccine candidate against challenge in a caprine model. Clin Vaccine Immunol. 2013;20(4):572-81.
Johne's disease (JD) is prevalent worldwide and has a significant impact on the global agricultural economy. In the present study, we evaluated the protective efficacy of a leuD (?leud) mutant and gained insight into differential immune responses after challenge with virulent M. avium subsp. paratuberculosis in a caprine colonization model. The immune response and protective efficacy were compared with those of the killed vaccine Mycopar. In vitro stimulation of peripheral blood mononuclear cells with johnin purified protein derivative showed that Mycopar and ?leuD generated similar levels of gamma interferon (IFN-?) but significantly higher levels than unvaccinated and challenged phosphate-buffered saline controls. However, only with ?leuD was the IFN-? response maintained. Flow cytometric analysis showed that the increase in IFN-? correlated with proliferation and activation (increased expression of CD25) of CD4, CD8, and ?dT cells, but this response was significantly higher in ?leuD-vaccinated animals at some time points after challenge. Both Mycopar and ?leuD vaccines upregulated Th1/proinflammatory and Th17 cytokines and downregulated Th2/anti-inflammatory and regulatory cytokines at similar levels at almost all time points. However, significantly higher levels of IFN-? (at weeks 26 and 30), interleukin-2 (IL-2; week 18), IL-1b (weeks 14 and 22), IL-17 (weeks 18 and 22), and IL-23 (week 18) and a significantly lower level of IL-10 (weeks 14 and 18) and transforming growth factor ß (week 18) were detected in the ?leuD-vaccinated group. Most importantly, ?leuD elicited an immune response that significantly limited colonization of tissues compared to Mycopar upon challenge with wild-type M. avium subsp. paratuberculosis. In conclusion, the ?leuD mutant is a promising vaccine candidate for development of a live attenuated vaccine for JD in ruminants.